v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss $ (49,075) $ (16,829)   $ (22,328) $ (3,681) $ (65,904) $ (26,009)  
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization 900         1,677 1,449  
Amortization of intangible assets 4,734     4,774   9,468 9,548  
Non-cash lease expense           896 1,178  
Stock-based compensation expense           6,059 26,639  
Allowance for expected credit losses           750 0 $ 7,619
Equity method investment loss 225     0   505 0  
Loss on disposition of capital assets           8 0  
Loss (Gain) from change in fair value of earnout liability 27,964     (7,550)   19,851 (33,749)  
Deferred income taxes           (35) 0  
Change in operating assets and liabilities:                
Accounts receivable           756 3,179  
Inventories           353 (2,925)  
Prepaid expenses and other current assets           (6) 1,431  
Other assets           954 576  
Accounts payable, accrued compensation and other accrued expenses           728 (10,373)  
Operating lease liability           (825) (1,103)  
Customer deposit and deferred revenue           0 (4,749)  
Net cash used in operating activities           (24,765) (34,908)  
CASH FLOWS FROM INVESTING ACTIVITIES:                
Proceeds from disposition of capital assets           46 0  
Investment purchases           0 (2,500)  
Purchases of property and equipment           (720) (5,639)  
Net cash used in investing activities           (674) (8,139)  
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from the issuance of the At-the-market offerings (ATM One and ATM Two)           100,000 0  
Costs for the issuance of common stock/At-the-market offering (ATM One and ATM Two)           (3,250) 0  
Proceeds from issuance of common stock in connection stock option exercises           1,023 415  
Proceeds from employee stock purchase plan           818 1,788  
Payments on finance lease obligations           (51) 0  
Net cash provided by financing activities           98,540 2,203  
NET INCREASE (DECREASE) IN CASH           73,101 (40,844)  
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD   $ 88,240     $ 152,839 88,240 152,839 $ 152,839
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD 161,341   $ 88,240 111,995   161,341 111,995  
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:                
Cash paid for income taxes           187 116  
Capital expenditures in accounts payable           $ 267 $ 414  
Conversion of Stock, Shares Issued           2,988,000 7,707,000  
Noncash Investing and Financing Items [Abstract]           985 —  
Cash and cash equivalents 161,189   $ 86,737 111,687   $ 161,189 $ 111,687  
Restricted Cash and Cash Equivalents $ 152     $ 308   $ 152 308  
Exercised (in shares)   (1,155,000) (236,000)          
Exercised (in dollars per share)   $ 0.77 $ 0.55          
Option to acquire aggregate shares of Common Stock (in shares) 108,000 1,263,000 1,499,000     108,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 0.74 $ 0.77 $ 0.74     $ 0.74    
Weighted average remaining contractual term (in years)   4 years 1 month 6 days           4 years 8 months 12 days
Cash paid for interest           $ 8 $ 0  
Vested and exercisable at the end (in dollars per share) $ 4.1         $ 4.1